Credit Ratings

Big Tech giants are facing unprecedented financial strain due to massive AI infrastructure investments. Companies like Meta, Amazon, and Alphabet are increasing debt and exploring new financing methods as capital expenditures surpass operating cash flow. While core businesses remain strong and credit ratings are currently high, escalating leverage and negative free cash flow trends are putting pressure on their financial health, prompting investors to closely monitor credit quality and the eventual return on AI investments.

Teva Pharmaceutical Industries has received upgraded credit ratings and a positive outlook from S&P and Moody’s. These actions reflect the company’s successful “Pivot to Growth” strategy, evidenced by consistent deleveraging and a return to revenue growth. Strong performance in branded medicines and upcoming biosimilar launches are key drivers, offsetting generics headwinds. This signifies Teva’s progress toward financial health and potentially investment-grade status.